Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis

PURPOSE: To systematically review anatomical and functional outcomes subsequent to switching from bevacizumab/ranibizumab to aflibercept monotherapy in patients with treatment-resistant neovascular age-related macular degeneration (nAMD). DESIGN: Systematic review and meta-analysis. METHODS: Medline...

Descripción completa

Detalles Bibliográficos
Autores principales: Spooner, Kimberly, Hong, Thomas, Wijeyakumar, Wijeyanthy, Chang, Andrew A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5229260/
https://www.ncbi.nlm.nih.gov/pubmed/28123287
http://dx.doi.org/10.2147/OPTH.S125676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5229260/
https://www.ncbi.nlm.nih.gov/pubmed/28123287
http://dx.doi.org/10.2147/OPTH.S125676

Ejemplares similares